KR101570966B1 - 타마린드 씨 다당류와 히알루론산에 기초된 안과 조성물 - Google Patents

타마린드 씨 다당류와 히알루론산에 기초된 안과 조성물 Download PDF

Info

Publication number
KR101570966B1
KR101570966B1 KR1020107006416A KR20107006416A KR101570966B1 KR 101570966 B1 KR101570966 B1 KR 101570966B1 KR 1020107006416 A KR1020107006416 A KR 1020107006416A KR 20107006416 A KR20107006416 A KR 20107006416A KR 101570966 B1 KR101570966 B1 KR 101570966B1
Authority
KR
South Korea
Prior art keywords
tsp
hyaluronic acid
weight
tamarind seed
seed polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020107006416A
Other languages
English (en)
Korean (ko)
Other versions
KR20100091151A (ko
Inventor
안토니오 델 프레테
마르코 산소
Original Assignee
알엠에프에이 트레이딩 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알엠에프에이 트레이딩 에스.에이. filed Critical 알엠에프에이 트레이딩 에스.에이.
Publication of KR20100091151A publication Critical patent/KR20100091151A/ko
Application granted granted Critical
Publication of KR101570966B1 publication Critical patent/KR101570966B1/ko
Assigned to 에이치엠프라 헝가리 리미티드 라이어빌리티 컴퍼니 reassignment 에이치엠프라 헝가리 리미티드 라이어빌리티 컴퍼니 권리의 전부이전등록 Assignors: 알엠에프에이 트레이딩 에스.에이.
Assigned to 아이티에이치 에스.알.엘. reassignment 아이티에이치 에스.알.엘. 권리의 전부이전등록 Assignors: 에이치엠프라 헝가리 리미티드 라이어빌리티 컴퍼니
Assigned to 파르미게아 에스.피.에이 reassignment 파르미게아 에스.피.에이 권리의 전부이전등록 Assignors: 아이티에이치 에스.알.엘.
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020107006416A 2007-10-02 2008-10-02 타마린드 씨 다당류와 히알루론산에 기초된 안과 조성물 Expired - Fee Related KR101570966B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM2007A000510 2007-10-02
IT000510A ITRM20070510A1 (it) 2007-10-02 2007-10-02 Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.

Publications (2)

Publication Number Publication Date
KR20100091151A KR20100091151A (ko) 2010-08-18
KR101570966B1 true KR101570966B1 (ko) 2015-11-23

Family

ID=40314052

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107006416A Expired - Fee Related KR101570966B1 (ko) 2007-10-02 2008-10-02 타마린드 씨 다당류와 히알루론산에 기초된 안과 조성물

Country Status (14)

Country Link
US (1) US8455462B2 (https=)
EP (1) EP2197456B1 (https=)
JP (1) JP5542674B2 (https=)
KR (1) KR101570966B1 (https=)
AT (1) ATE499106T1 (https=)
CA (1) CA2701721C (https=)
DE (1) DE602008005173D1 (https=)
ES (1) ES2361529T3 (https=)
IT (1) ITRM20070510A1 (https=)
MX (1) MX2010003488A (https=)
PL (1) PL2197456T3 (https=)
PT (1) PT2197456E (https=)
RU (1) RU2493855C2 (https=)
WO (1) WO2009044423A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1861069B2 (en) * 2005-02-09 2013-07-03 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
IT1396607B1 (it) * 2009-11-16 2012-12-14 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
SG185693A1 (en) * 2010-05-24 2012-12-28 Indena Spa Tamarind seed polysaccharide for use in the treatment of microbial infections
SI2575973T1 (sl) * 2010-05-24 2017-10-30 Indena S.P.A. Polisaharid semen tamarinde in ekstrakt iz ferula hermonis, za uporabo pri zdravljenju vnetnih bolezni
FR2963240B1 (fr) * 2010-07-28 2013-03-15 Horus Pharma Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
IT1404145B1 (it) * 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
EP2883931A1 (en) * 2013-12-12 2015-06-17 Omya International AG Improved gel stability
CA2945631C (en) 2014-04-15 2023-04-11 Novintethical Pharma Sa Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
EP3103438B1 (en) 2015-06-11 2018-11-14 Novintethical Pharma SA Topical nasal compositions containing xyloglucans for use as decongestans
HK1255867A1 (zh) * 2015-07-13 2019-08-30 东北泰克诺亚奇股份有限公司 视神经保护用组合物
AR108280A1 (es) 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
IT201600108848A1 (it) * 2016-10-27 2018-04-27 Giuliani Spa Composizioni dermatologiche
US10702578B2 (en) * 2017-08-02 2020-07-07 Shilpa Medicare Limited Ophthalmic compositions of cyclosporine
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
US11406658B2 (en) * 2018-07-18 2022-08-09 Atg 20 S.R.L. Composition comprising glycyrrhizin and cosmetic and pharmaceutical uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100430260B1 (ko) 1996-02-05 2004-07-30 파르미게 에스.피.에이. 타마린드씨폴리사카라이드로점성을제공한안약
WO2006085351A1 (en) 2005-02-09 2006-08-17 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
EP1021204B1 (en) * 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
DE69825495T2 (de) * 1998-12-23 2005-07-28 Idea Ag Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
EP1667705A1 (en) * 2003-10-03 2006-06-14 Allergan, Inc. Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100430260B1 (ko) 1996-02-05 2004-07-30 파르미게 에스.피.에이. 타마린드씨폴리사카라이드로점성을제공한안약
WO2006085351A1 (en) 2005-02-09 2006-08-17 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens

Also Published As

Publication number Publication date
CA2701721A1 (en) 2009-04-09
JP5542674B2 (ja) 2014-07-09
JP2010540619A (ja) 2010-12-24
US8455462B2 (en) 2013-06-04
US20100279981A1 (en) 2010-11-04
PT2197456E (pt) 2011-05-18
PL2197456T3 (pl) 2012-07-31
ITRM20070510A1 (it) 2009-04-03
WO2009044423A1 (en) 2009-04-09
KR20100091151A (ko) 2010-08-18
EP2197456B1 (en) 2011-02-23
EP2197456A1 (en) 2010-06-23
DE602008005173D1 (de) 2011-04-07
RU2010117173A (ru) 2011-11-10
ES2361529T3 (es) 2011-06-17
MX2010003488A (es) 2010-08-31
CA2701721C (en) 2016-02-23
RU2493855C2 (ru) 2013-09-27
ATE499106T1 (de) 2011-03-15

Similar Documents

Publication Publication Date Title
KR101570966B1 (ko) 타마린드 씨 다당류와 히알루론산에 기초된 안과 조성물
JP3872515B2 (ja) タマリンド種子多糖で粘稠化された点眼液
RU2663449C2 (ru) Глазные композиции, содержащие мукоадгезивные полисахариды, способные стимулировать восстановление эпителия роговицы
DE69513902T2 (de) Augenpräparat zur Verwendung in künstlicher Tränenflüssigkeit
DE60024594T2 (de) Ophthalmologische zubereitung die mucin enthält
DE10161149B4 (de) Verwendung von Heparin-haltigem Ophthalmikum
CN108697635B (zh) 用于治疗与角膜-结膜表面改变有关的眼病的眼科组合物
KR20190004275A (ko) 글리코겐 및 히알루론산 또는 이의 염의 상승 작용 조합을 포함하는 안과 조성물
HK1224558A (en) Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization
HK1224558A1 (en) Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

T12-X000 Administrative time limit extension not granted

St.27 status event code: U-3-3-T10-T12-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

FPAY Annual fee payment

Payment date: 20181018

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20241118

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-OTH-PC1903 (AS PROVIDED BY THE NATIONAL OFFICE); TERMINATION CATEGORY : DEFAULT_OF_REGISTRATION_FEE

Effective date: 20241118

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20241118